Trials / Completed
CompletedNCT06627920
Validation of a Smartwatch for Blood Pressure Monitoring
Validation of a Smartwatch for Blood Pressure Measurement
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 101 (actual)
- Sponsor
- European University Miguel de Cervantes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Accurate measurement of blood pressure is essential for the assessment of cardiovascular health and the prevention of cardiovascular disease. Smartwatches have emerged as a promising option for continuous monitoring of blood pressure outside the clinical setting. This study aims to validate the use of the smartwatch KC08 for blood pressure measurement, which is a cost-effective and convenient alternative for blood pressure measurement. A cross-sectional study will be conducted with participants aged greater than or equal to18 years. The measurements of blood pressure, heart rate and oxygen saturation will be performed with the smartwatch KC08, the Beurer PO30 pulse oximeter and the Omron M7 BP monitor. The statistical analysis will evaluate the reliability of the devices and compare the measurements of the two devices using different statistical methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Use of the KC08 smartwatch, Beurer PO30 and Omron M7 BP monitor. | Use of the KC08 smartwatch, Beurer PO30 and Omron M7 BP monitor to estimate blood pressure, heart rate and oxygen saturation. |
Timeline
- Start date
- 2024-07-10
- Primary completion
- 2024-11-21
- Completion
- 2024-11-21
- First posted
- 2024-10-04
- Last updated
- 2025-02-27
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06627920. Inclusion in this directory is not an endorsement.